Nexstim Plc (NXTMH.HE)
EUR 7.64
(9.46%)
EUR 7.64
(9.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.31 Million EUR | -80.54% |
| 2022 | 9.52 Million EUR | 53.07% |
| 2021 | 6.22 Million EUR | 97.81% |
| 2020 | 3.14 Million EUR | 36.61% |
| 2019 | 2.3 Million EUR | 40.57% |
| 2018 | 1.63 Million EUR | 166.62% |
| 2017 | 614.18 Thousand EUR | -7.89% |
| 2016 | 666.79 Thousand EUR | 134.24% |
| 2015 | -1.94 Million EUR | -294.23% |
| 2014 | -494.03 Thousand EUR | -139.73% |
| 2013 | 1.24 Million EUR | -49.04% |
| 2012 | 2.43 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 697.7 Thousand EUR | 0.0% |
| 2023 FY | 1.85 Million EUR | -80.54% |
| 2023 Q2 | 85.8 Thousand EUR | -93.55% |
| 2023 Q3 | 2.16 Million EUR | 2419.39% |
| 2023 Q1 | 1.33 Million EUR | 1608.27% |
| 2023 Q4 | 1.76 Million EUR | -18.24% |
| 2022 Q3 | 1.34 Million EUR | -67.34% |
| 2022 Q4 | 77.87 Thousand EUR | -94.21% |
| 2022 Q2 | 4.11 Million EUR | 20.53% |
| 2022 FY | 9.52 Million EUR | 53.07% |
| 2022 Q1 | 3.41 Million EUR | 330.5% |
| 2021 Q2 | 635.8 Thousand EUR | -55.17% |
| 2021 FY | 6.22 Million EUR | 97.81% |
| 2021 Q4 | 793.5 Thousand EUR | -55.71% |
| 2021 Q3 | 1.79 Million EUR | 181.81% |
| 2021 Q1 | 1.41 Million EUR | 420.97% |
| 2020 Q3 | 932.92 Thousand EUR | 282.32% |
| 2020 Q2 | -511.7 Thousand EUR | -177.9% |
| 2020 Q1 | 656.9 Thousand EUR | 143.98% |
| 2020 FY | 3.14 Million EUR | 36.61% |
| 2020 Q4 | -441.9 Thousand EUR | -147.37% |
| 2019 Q3 | 726.43 Thousand EUR | 151.88% |
| 2019 FY | 2.3 Million EUR | 40.57% |
| 2019 Q1 | 445.35 Thousand EUR | -30.9% |
| 2019 Q2 | -1.4 Million EUR | -414.43% |
| 2019 Q4 | -1.49 Million EUR | -305.63% |
| 2018 Q1 | 367.15 Thousand EUR | -39.63% |
| 2018 FY | 1.63 Million EUR | 166.62% |
| 2018 Q4 | 644.46 Thousand EUR | 0.0% |
| 2018 Q2 | 367.15 Thousand EUR | 0.0% |
| 2018 Q3 | 644.46 Thousand EUR | 75.53% |
| 2017 Q3 | 608.15 Thousand EUR | 32.83% |
| 2017 FY | 614.18 Thousand EUR | -7.89% |
| 2017 Q2 | 457.85 Thousand EUR | 0.0% |
| 2017 Q1 | 457.85 Thousand EUR | -19.54% |
| 2017 Q4 | 608.15 Thousand EUR | 0.0% |
| 2016 Q2 | 340.95 Thousand EUR | 0.0% |
| 2016 Q4 | 569.04 Thousand EUR | 0.0% |
| 2016 FY | 666.79 Thousand EUR | 134.24% |
| 2016 Q3 | 569.04 Thousand EUR | 66.9% |
| 2016 Q1 | 340.95 Thousand EUR | -45.63% |
| 2015 Q4 | 627.13 Thousand EUR | 0.0% |
| 2015 Q3 | 627.13 Thousand EUR | 119.66% |
| 2015 FY | -1.94 Million EUR | -294.23% |
| 2015 Q1 | 285.5 Thousand EUR | -59.03% |
| 2015 Q2 | 285.5 Thousand EUR | 0.0% |
| 2014 Q3 | 696.77 Thousand EUR | 315.74% |
| 2014 FY | -494.03 Thousand EUR | -139.73% |
| 2014 Q4 | 696.77 Thousand EUR | 0.0% |
| 2014 Q2 | 167.6 Thousand EUR | 0.0% |
| 2014 Q1 | 167.6 Thousand EUR | -69.3% |
| 2013 Q3 | 545.85 Thousand EUR | 403.09% |
| 2013 Q4 | 545.85 Thousand EUR | 0.0% |
| 2013 Q2 | 108.5 Thousand EUR | 0.0% |
| 2013 FY | 1.24 Million EUR | -49.04% |
| 2013 Q1 | 108.5 Thousand EUR | -82.21% |
| 2012 FY | 2.43 Million EUR | 0.0% |
| 2012 Q1 | 609.9 Thousand EUR | 0.0% |
| 2012 Q2 | 609.9 Thousand EUR | 0.0% |
| 2012 Q3 | 609.9 Thousand EUR | 0.0% |
| 2012 Q4 | 609.9 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | -3619.00 EUR | 63983.283% |
| Modulight Oyj | 1.06 Million EUR | -117.492% |
| Revenio Group Oyj | 45.27 Million EUR | 94.894% |